37.19
price up icon0.81%   0.30
pre-market  Pre-mercato:  37.19  
loading

Perché le azioni Revolution Medicines Inc (RVMD) sono in ribasso?

Abbiamo notato un calo di 7.03% nelle azioni di Revolution Medicines Inc (RVMD) durante la sessione di negoziazione di 2025-05-27. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-10-23:

Shares of Revolution Medicines (RVMD) dropped by 34.38% from $27.97 to $18.36 in the trading on Monday, October 23, 2023. The reason why RVMD stock down is due to the release of data from their RMC-6236 phase 1 study targeting NSCLC and PDAC treatment at the ESMO Congress in Madrid. Expectations were high, with RVMD's stock having risen over 40% year-to-date just the previous week. However, RMC-6236's performance disappointed, with an objective response rate of only 30% in NSCLC after unconfirmed responses were excluded. In PDAC, only 19.6% of patients achieved a partial response, with four of them being unconfirmed. RVMD's CEO expressed confidence in RMC-6236, but analyst Jonathan Chang noted that the results may have fallen short of investor expectations.

$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):